What is the recommended treatment for hypomagnesemia in adults?

Treatment for Hypomagnesemia in Adults

For symptomatic or severe hypomagnesemia (serum Mg <1.2 mg/dL), administer intravenous magnesium sulfate 1-2 g IV push; for asymptomatic patients, use oral magnesium supplementation with 12-24 mmol daily (typically magnesium oxide), preferably at night. 1

Immediate Assessment and Treatment Algorithm

Step 1: Determine Severity and Symptoms

Severe/Symptomatic (Mg <1.2 mg/dL or any cardiac manifestations):

• Cardiac arrest or life-threatening arrhythmias (torsades de pointes, polymorphic VT): IV magnesium sulfate 1-2 g bolus IV push immediately 2, 1
• Symptomatic but stable (neuromuscular symptoms, seizures, tetany): IV magnesium sulfate 3, 4
• Reserve parenteral therapy for symptomatic patients only 5, 6

Asymptomatic (Mg 1.2-1.8 mg/dL):

• Oral magnesium replacement is appropriate 4, 5

Step 2: Correct Underlying Factors FIRST

Critical prerequisite steps before magnesium replacement:

1. Correct water and sodium depletion - This is the most important first step, particularly in patients with secondary hyperaldosteronism 7
2. Verify adequate renal function - Required before administering any magnesium supplementation 5
3. Identify and address the cause:
   • Discontinue offending medications (PPIs, diuretics, cisplatin, cetuximab, aminoglycosides, amphotericin B) 8, 9, 10
   • Treat gastrointestinal losses (diarrhea, malabsorption, short bowel syndrome)
   • Address renal wasting syndromes

Step 3: Oral Magnesium Replacement Protocol

For asymptomatic patients or maintenance therapy:

• Magnesium oxide 12-24 mmol daily (160 mg MgO = 4 mmol elemental Mg) 7
• Timing: Give at night when intestinal transit is slowest to maximize absorption 7
• Multiple daily dosing preferred for optimal absorption and sustained serum levels 8
• Take with meals to serve as phosphate binder and improve calcium absorption 8

Important caveat: Most oral magnesium salts are poorly absorbed and may worsen diarrhea/stomal output in patients with gastrointestinal disease 7

Step 4: Advanced Oral Therapy (If Standard Replacement Fails)

If oral magnesium supplements do not normalize levels:

• Add oral 1-alpha hydroxycholecalciferol (calcitriol) starting at 0.25 μg daily, gradually increasing every 2-4 weeks up to 9.0 mg daily 8, 7
• Monitor serum calcium regularly to avoid hypercalcemia 7
• Magnesium is a cofactor for adenylate cyclase; inadequate intracellular magnesium causes PTH resistance 8

Step 5: Parenteral Therapy Options

Intravenous administration:

• Add 4-12 mmol magnesium sulfate to saline bags for IV infusion 7, 11
• For patients requiring frequent replacement (>3 times weekly), use IV route 7

Subcutaneous administration:

• 0.5-1 L saline with 4 mmol magnesium sulfate subcutaneously 7
• Appropriate if only needed 1-3 times per week 7

Special Populations and Contexts

Cardiac Arrest Setting

• Class I recommendation (strongest): For cardiotoxicity and cardiac arrest from severe hypomagnesemia, IV magnesium 1-2 g MgSO₄ bolus IV push 2, 1
• Hypomagnesemia associated with polymorphic VT and torsades de pointes 1

Cancer Patients

• Chemotherapy-induced (cisplatin, cetuximab): Magnesium replacement recommended 3
• Can cause confusion, hallucinations, irritability, nystagmus, seizures, contractures, severe pain 3
• IV magnesium sulfate may reverse neurological symptoms 3

Short Bowel Syndrome/Jejunostomy

• Hypomagnesemia is common, especially with outputs >2 L/day 7
• Five-step approach:
  1. Correct water/sodium depletion (secondary hyperaldosteronism)
  2. Oral magnesium (12 mmol magnesium oxide at night)
  3. Reduce/avoid excess dietary lipid
  4. Oral 1-alpha cholecalciferol (0.25-9.0 mg daily)
  5. IV/SC magnesium if needed 7

Hypoparathyroidism

• Correct serum magnesium levels as inadequate intracellular magnesium results in PTH resistance 8
• High serum magnesium can lower PTH synthesis/secretion by binding to calcium-sensing receptor 8
• Intracellular magnesium deficiency is significant when serum magnesium is low - replace accordingly 8

Common Pitfalls to Avoid

1. Do NOT give oral magnesium alone without correcting sodium/water depletion first - this is the most common error 7
2. Do NOT administer magnesium without verifying adequate renal function 5
3. Do NOT use IV magnesium for asymptomatic patients - reserve for symptomatic/severe cases 4, 5
4. Do NOT forget to check and correct concurrent electrolyte abnormalities - hypomagnesemia commonly coexists with hypokalemia, hypocalcemia, and metabolic alkalosis 4
5. Do NOT overlook drug-induced causes - PPIs are increasingly recognized as culprits 4, 9, 10

Monitoring Strategy

• Symptomatic patients: Daily magnesium levels until stable
• Asymptomatic patients on replacement: Check levels 2-3 days after dose changes 8
• Long-term PN (>30 days): Monitor when manganese intake >55 mg/day with liver impairment 12
• Target serum magnesium: >1.8 mg/dL (>0.74 mmol/L) 5

The evidence strongly supports a stepwise approach prioritizing correction of volume status and sodium depletion before magnesium replacement, with route of administration determined by symptom severity rather than absolute magnesium level alone.